Roche projects drug-sales growth of up to 8% in '01

Article Abstract:

Roche Holding AG forecasted that its drug sales will increase to close to the industry average by 2001. The company expects to see as much as 8% growth in drug sales in 2001.

---

Roche sees operating margin shrinking this year (Roche Holding AG)

Article Abstract:

Swiss pharmaceuticals giant Roche Holding Ltds., expects a reduced margin of profit for the year due to its high marketing costs. Also, the expirations of patents for some of its key products would affect sales figures for the year 2001.

Market information - general, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations

---

AstraZeneca beats market expectations for pretax profit

Article Abstract:

AstraZeneca PLC posted higher-than-expected pretax profits for the 2001 first-quarter. However, the company, which posted $1.09 billion (1.22 billion euros) in pretax profits for the period, could see its future results impacted by a weaker second-quarter.

United Kingdom, AstraZeneca PLC, AZN

Similar abstracts:

• Abstracts: Roche, Decode claim they located gene linked to Alzheimer disease (DeCode Genetics Inc., and Roche Holding AG)
• Abstracts: Ratings agency wants to clarify operating earnings; S&P hopes to clean up corporate profit reports. U.S. earnings growth to slow a bit
• Abstracts: Sea change: Exxon Mobil bets on new technology in hunt for gold. Sakhalin Oil find holds promise
• Abstracts: Despite online trading threat, securities firms go on hiring spree. Many on Wall Street back Al Gore
• Abstracts: EADS posts 93 million euros loss, widening on the weak dollar. Dassault Aviation net profit dropped by 15% last year

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.